This news has been received from: cvbj.biz
All trademarks, copyrights, videos, photos and logos are owned by respective news sources. News stories, videos and live streams are from trusted sources.
The journalist Julia Otero, director and presenter of the program Julia on the wave, announced this Monday that suffers from cancer. Fortunately, the news seems favorable for Otero, since has been detected in time, as collected Informal.
Sources of Zero Wave, the chain where the presenter works, assured Informal who has intestinal cancer.“Just a few cells that have been seen when doing some tests,” they point out, adding: “Julia Otero is going to win this battle against colon cancer.”
“The word cancer is scary, but I’m learning to pronounce it in the first person for six days, “acknowledged the journalist when she announced that she suffers from colon cancer and added that” it was not easy. “” You have to call things by their name, “he said.
News Source: cvbj.biz
Health experts fear future surge in cancer deaths after pandemic-related delays in screenings
Public health experts fear the delays in cancer screenings and treatments caused by the response to the coronavirus pandemic will cause a future spike in cancer deaths long after the pandemic is over.
"Delays in diagnosis are common. Interruptions in therapy or abandonment have increased significantly," said Dr. André Ilbawi of the World Health Organization’s Department of Noncommunicable Diseases.
Ilbawi said 50% of governments have seen cancer treatments "partially or completely disrupted because of the pandemic," which is likely to have an impact on cancer deaths in future years.
The U.S. Centers for Disease Control and Prevention estimates that American life expectancy has fallen by one year during the first half of 2020, a result of not only deaths directly tied to COVID-19 but also in other conditions that are going untreated or unnoticed.
900,000 EXCESS DEATHS EXPECTED OVER NEXT 15 YEARS FROM PANDEMIC RISE IN UNEMPLOYMENT
"To see the change in life expectancy that quickly in 2020 just illustrates how much of a threat to the population this pandemic has been," said Dr. Richard Wender, a physician with Penn Medicine.
Wender, who previously served as chief cancer control officer for the American Cancer Society, points to the organization’s decision in March of last year to recommend temporarily delaying cancer screenings as a turning point.
"We realized how profound of a decision that was — that there were cancers or pre-cancers for which the diagnosis would be delayed," he recalled of that decision.
"When restrictions lift, it’s important to reschedule any screening test that you’re due to receive," Wender said. "Getting back on track with cancer screenings should be a high priority."
But a survey by the Prevent Cancer Foundation found that 52% of Americans have missed, postponed, or canceled routine medical appointments since the pandemic began, with most citing fear of COVID-19 exposure as the primary reason for the delay.
The survey also found that two-thirds of Americans are not receiving the recommended cancer screenings, while 32% are unaware of which screenings they need.
Doctors say they now know how to safely care for cancer patients, which should give Americans confidence that they can return for their screenings. But many patients are still delaying care.
"I’m absolutely positive that the effects of COVID-19 are still being felt by individuals and are having a significant impact on their comfort level in seeking any healthcare, let alone preventative care," Wender said. "Transmission, as a part of routine cancer screening, is almost zero. We have learned how to keep people safe.”
Even moderate delays in cancer screenings can have a profound impact on patient outcomes, turning what could have been a more routine treatment plan into an emergency by the time problems are discovered.
"Even a delay of six to eight weeks can be enough to change prognosis. We have some patients, if they don’t respond to symptoms, have something that could have been handled more routinely and electively actually turn into an emergency," Wender said.
Compounding matters for cancer patients have been disruptions with clinical trials as the pandemic lags on, with around 80% of non-COVID-19 trials being stopped or interrupted since the pandemic began.
The American Cancer Society is now urging people at higher risk of cancer to get the coronavirus vaccine as soon as it’s available to them, with the hope that those patients will return to routine screenings and treatments.
CLICK HERE TO READ MORE FROM THE WASHINGTON EXAMINER
"The main concern about getting the vaccine is not whether it’s safe for people with cancer, but about how effective it will be, especially in people with weakened immune systems," the American Cancer Society says on its website.
"Like a lot of things in life, there’s no one profile of a cancer survivor," Wender added.News Coronavirus Cancer CDC